GOSS Gossamer Bio, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$10.71
· of 52w range
· above low
· to high
$9.1252w low
$309.6052w high
Market Cap (MRQ)
$5.24B
P/E (TTM)
-15.3
EPS (TTM)
$-0.70
Revenue (TTM)
$53M
your badges
52W Range
$9–$310
Analyst Rating
BUY
Price Target
$82
P/E
-15.3
ROE
178.7%
Net Profit Margin
-235.0%
Your badge strip is empty — pin a metric anywhere on this page.
GOSS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.71
Market Cap (MRQ)
$5.24B
P/E (TTM)
-15.3
EPS (TTM)
$-0.70
Revenue (TTM)
$53M
ROE (TTM)
178.7%
52W Range
$9–$310
GOSS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Sept. 11, 2026 | 1-for-80 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$48M2022-12-31 → 2025-12-31
EPS$-0.752019-12-31 → 2025-12-31
Free Cash Flow$-171M2019-12-31 → 2025-12-31
Net margin-235.0%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | GOSS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -15.35Y avg ≈-2.6 | ≈-2.6 | · | · | |
| P/S (TTM) | 98.3 | · | 236.5 | Undervalued | |
| P/B (MRQ) | -55.75Y avg ≈5.7 | ≈5.7 | · | · | |
| Price / FCF (TTM) | -32.25Y avg ≈-14.0 | ≈-14.0 | · | · | |
| Price / Cash Flow (TTM) | -32.25Y avg ≈-14.1 | ≈-14.1 | · | · | |
| Price / Tangible Book | 24.15Y avg ≈8.6 | ≈8.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | GOSS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -311.7% | · | -4230.3% | Top tier | |
| EBITDA Margin | -352.2% | · | -4230.3% | Top tier | |
| Pretax Margin | -351.7% | · | -351.7% | In line | |
| Net Profit Margin (TTM) | -235.0% | · | -4255.7% | Top tier | |
| ROA (TTM) | -78.8%5Y avg ≈-55.4% | ≈-55.4% | -60.2% | Weak | |
| ROE (TTM) | 178.7%5Y avg ≈-195.9% | ≈-195.9% | -59.2% | Top tier | |
| ROIC | 139.0% | · | -38.7% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | GOSS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.55Y avg ≈5.8 | ≈5.8 | 5.2 | Low liquidity | |
| Quick Ratio (MRQ) | 0.55Y avg ≈5.6 | ≈5.6 | 5.1 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | GOSS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -57.7% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | GOSS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | 0.0 | Top tier | |
| Receivables Turnover | 5.5 | · | · | · | |
| Revenue / Employee | ≈$301.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
20.9%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $4.00 | $-10.14 | 139.4% |
| March 31, 2026 | May 15, 2026 | $-16.00 | $-13.48 | -18.7% |
| Dec. 31, 2025 | $-0.21 | $-0.20 | -5.2% | |
| Sept. 30, 2025 | $-0.21 | $-0.20 | -7.4% | |
| June 30, 2025 | $-0.17 | $-0.18 | 8.0% | |
| March 31, 2025 | $-0.16 | $-0.19 | 16.4% | |
| Dec. 31, 2024 | $-0.15 | $-0.17 | 13.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $48M | $115M | $0 | $0 | |
| SG&A Expense | $38M | $36M | $38M | $48M | |
| Operating Expenses | $219M | $175M | $184M | $219M | |
| Operating Income | $-171M | $-60M | $-184M | $-219M | |
| Interest Expense | · | · | $14M | $14M | |
| Interest Income | $2M | $2M | $2M | $2M | |
| Other Non-op | $9M | $14M | $15M | $2M | |
| Pretax Income | $-170M | $-56M | $-180M | $-229M | |
| Income Tax | $-88.0K | $893.0K | $0 | $0 | |
| Net Income | $-170M | $-57M | $-180M | $-229M | |
| EPS (Basic) | $-0.75 | $-0.25 | $-1.18 | $-2.71 | |
| EPS (Diluted) | $-0.75 | $-0.25 | $-1.18 | $-2.71 | |
| Shares (Basic) | 228,519,130 | 226,228,016 | 152,621,669 | 84,574,869 | |
| Shares (Diluted) | 228,519,130 | 226,228,016 | 152,621,669 | 84,574,869 | |
| EBITDA | $-171M | $-59M | $-182M | $-217M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $46M | $32M | $112M | |
| Short-term Investments | $99M | $248M | $264M | $144M | |
| Receivables | $12M | $5M | $0 | · | |
| Prepaid Expense | $18M | $10M | $10M | $6M | |
| Current Assets | $168M | $310M | $307M | $262M | |
| PP&E (Net) | $64.0K | $10.0K | $2M | $4M | |
| PP&E (Gross) | $271.0K | $193.0K | $7M | $10M | |
| Accum. Depreciation | $207.0K | $183.0K | $5M | $6M | |
| Other Non-current Assets | $408.0K | $283.0K | $618.0K | $680.0K | |
| Total Assets | $172M | $315M | $312M | $272M | |
| Accounts Payable | $6M | $2M | $6M | $1M | |
| Accrued Liabilities | $16M | $15M | $27M | $21M | |
| Current Liabilities | $63M | $45M | $52M | $49M | |
| Capital Leases | $3M | $4M | $144.0K | $3M | |
| Total Liabilities | $295M | $286M | $249M | $260M | |
| Long-term Debt | · | $0 | $12M | $24M | |
| Total Debt | · | $0 | $12M | $24M | |
| Common Stock | $24.0K | $23.0K | $23.0K | $10.0K | |
| Retained Earnings | $-1.44B | $-1.27B | $-1.21B | $-1.03B | |
| AOCI | $-5M | $1M | $-350.0K | $-574.0K | |
| Stockholders' Equity | $-123M | $29M | $63M | $12M | |
| Liabilities + Equity | $172M | $315M | $312M | $272M | |
| Shares Outstanding | 233,677,057 | 226,604,138 | 225,409,315 | 94,423,181 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $24.0K | $833.0K | $2M | $2M | |
| Stock-based Comp | $11M | $21M | $29M | $43M | |
| Other Non-cash | $-11M | $32M | $-9M | $-2M | |
| Operating Cash Flow | $-171M | $-3M | $-159M | $-187M | |
| CapEx | $79.0K | $0 | $0 | $410.0K | |
| Investing Cash Flow | $156M | $29M | $-111M | $-1M | |
| Net Debt Issued | $0 | $-13M | $-12M | $-6M | |
| Stock Issued | · | · | · | $0 | |
| Net Stock Activity | · | · | · | $0 | |
| Financing Cash Flow | $6M | $-11M | $190M | $117M | |
| Net Change in Cash | $-8M | $14M | $-80M | $-71M | |
| Free Cash Flow | $-171M | $-3M | $-159M | $-187M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -352.2% | -52.2% | · | · | |
| Net Margin | -351.5% | -49.3% | · | · | |
| Pretax Margin | -351.7% | -48.5% | · | · | |
| EBITDA Margin | -352.2% | -51.5% | · | · | |
| ROA | -69.9% | -18.0% | -61.5% | -74.5% | |
| ROE | 201.8% | -135.2% | -214.8% | -670.4% | |
| ROIC | 139.0% | -206.4% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 2.6 | 6.9 | 5.9 | 5.3 | |
| Quick Ratio | 2.4 | 6.7 | 5.7 | 5.2 | |
| Debt / Equity | · | 0.0 | 0.2 | 2.0 | |
| LT Debt / Equity | · | 0.0 | 0.0 | 1.0 | |
| Interest Coverage | · | · | -13.6 | -15.7 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.4 | · | · | |
| Receivables Turnover | 5.5 | 43.0 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $-0.53 | $0.13 | $0.28 | $0.13 | |
| Revenue / Share | $0.21 | $0.51 | · | · | |
| Cash Flow / Share | $-0.75 | $-0.02 | $-1.04 | $-2.21 | |
| Cash / Share | $0.16 | $0.20 | $0.14 | $1.19 | |
| EPS (TTM) | $-0.75 | $-0.25 | $-1.18 | $-2.71 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -57.7% | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $48M | $115M | $0 | $0 | |
| Net Income TTM | $-170M | $-57M | $-180M | $-229M | |
| Market Cap | $724M | $205M | $206M | $205M | |
| Enterprise Value | · | $-89M | $-78M | $-27M | |
| P/E | -4.1 | -3.6 | -0.8 | -0.8 | |
| P/S | 14.9 | 1.8 | · | · | |
| P/B | -5.9 | 7.0 | 3.3 | 17.0 | |
| P / Tangible Book | · | 7.0 | 3.3 | 17.0 | |
| P / Cash Flow | -4.2 | -59.1 | -1.3 | -1.1 | |
| P / FCF | -4.2 | -59.1 | -1.3 | -1.1 | |
| EV / EBITDA | · | 1.5 | 0.4 | 0.1 | |
| EV / FCF | · | 25.8 | 0.5 | 0.1 | |
| EV / Revenue | · | -0.8 | · | · | |
| Earnings Yield | -24.2% | -27.6% | -129.2% | -124.9% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $17M | $14M | $13M | $11M | $10M | $9M | $9M | $96M | $0 | $0 | $0 | $0 | |
| SG&A Expense | $9M | $19M | $11M | $9M | $9M | $9M | $9M | $9M | $9M | $10M | $9M | $9M | $10M | |
| Operating Expenses | $35M | $62M | $60M | $62M | $50M | $47M | $46M | $43M | $44M | $42M | $49M | $40M | $46M | |
| Operating Income | $-26M | $-45M | $-46M | $-49M | $-39M | $-37M | $-36M | $-34M | $52M | $-42M | $-49M | $-40M | $-46M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | |
| Interest Income | $268.0K | $354.0K | $447.0K | $687.0K | $542.0K | $294.0K | $-744.0K | $430.0K | $2M | $344.0K | $310.0K | $405.0K | $695.0K | |
| Other Non-op | $-4M | $603.0K | $1M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $7M | |
| Pretax Income | · | · | $-47M | $-48M | $-38M | · | $-35M | $-32M | $54M | · | $-48M | $-40M | $-42M | |
| Income Tax | · | · | $-88.0K | $0 | $0 | · | $-2M | $-1M | $4M | · | $0 | $0 | $0 | |
| Net Income | $17M | $-47M | $-47M | $-48M | $-38M | $-37M | $-33M | $-31M | $49M | $-42M | $-48M | $-40M | $-42M | |
| EPS (Basic) | $0.05 | $-0.20 | $-0.21 | $-0.21 | $-0.17 | $-0.16 | $-0.14 | $-0.14 | $0.22 | $-0.19 | $0.00 | $-0.21 | $-0.45 | |
| EPS (Diluted) | $-0.08 | $-0.20 | $-0.21 | $-0.21 | $-0.17 | $-0.16 | $-0.14 | $-0.14 | $0.22 | $-0.19 | $0.00 | $-0.21 | $-0.45 | |
| Shares (Basic) | 320,014,255 | 234,137,364 | · | 227,981,475 | 227,275,466 | 226,818,051 | · | 226,346,058 | 226,221,202 | 225,735,236 | · | 192,883,209 | 95,446,929 | |
| Shares (Diluted) | 328,776,495 | 234,137,364 | · | 227,981,475 | 227,275,466 | 226,818,051 | · | 226,346,058 | 238,543,102 | 225,735,236 | · | 192,883,209 | 95,446,929 | |
| EBITDA | $-26M | $-45M | · | $-49M | $-39M | $-37M | · | $-34M | $52M | $-42M | · | $-40M | $-46M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $41M | $38M | $9M | $26M | $29M | $46M | $28M | $87M | $39M | · | $83M | $37M | |
| Short-term Investments | $16M | $58M | $99M | $171M | $187M | $229M | $248M | $299M | $268M | $206M | · | $246M | $125M | |
| Receivables | $6M | $9M | $12M | $9M | $8M | $7M | $5M | $7M | $4M | · | · | · | · | |
| Prepaid Expense | $10M | $16M | $18M | $15M | $15M | $11M | $10M | $11M | $13M | $11M | · | $13M | $11M | |
| Current Assets | $73M | $125M | $168M | $204M | $236M | $275M | $310M | $344M | $371M | $255M | · | $341M | $173M | |
| PP&E (Net) | $55.0K | $59.0K | $64.0K | $70.0K | $76.0K | $29.0K | $10.0K | $302.0K | $824.0K | $1M | · | $2M | $3M | |
| PP&E (Gross) | · | · | $271.0K | · | · | · | $193.0K | $4M | $6M | $6M | · | $7M | $10M | |
| Accum. Depreciation | · | · | $207.0K | · | · | · | $183.0K | $4M | $6M | $5M | · | $5M | $7M | |
| Other Non-current Assets | $429.0K | $398.0K | $408.0K | $407.0K | $383.0K | $310.0K | $283.0K | $283.0K | $59.0K | $613.0K | · | $649.0K | $770.0K | |
| Total Assets | $77M | $129M | $172M | $209M | $241M | $281M | $315M | $351M | $373M | $259M | · | $348M | $182M | |
| Accounts Payable | $6M | $11M | $6M | $1M | $2M | $3M | $2M | $3M | $1M | $3M | · | $1M | $2M | |
| Accrued Liabilities | $18M | $20M | $16M | $19M | $13M | $12M | $15M | $17M | $16M | $15M | · | $17M | $14M | |
| Current Liabilities | $138M | $57M | $63M | $62M | $54M | $48M | $45M | $51M | $45M | $36M | · | $42M | $40M | |
| Capital Leases | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $0 | $0 | · | $992.0K | $2M | |
| Total Liabilities | $171M | $290M | $295M | $291M | $287M | $287M | $286M | $297M | $292M | $233M | · | $243M | $245M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | $0 | $10M | · | $15M | $18M | |
| Total Debt | · | · | · | · | · | · | · | $0 | $0 | $10M | · | $15M | $18M | |
| Common Stock | $50.0K | $24.0K | $24.0K | $24.0K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | · | $23.0K | $10.0K | |
| Retained Earnings | $-1.47B | $-1.49B | $-1.44B | $-1.39B | $-1.34B | $-1.31B | $-1.27B | $-1.24B | $-1.20B | $-1.25B | · | $-1.16B | $-1.12B | |
| AOCI | $-4M | $-4M | $-5M | $-5M | $-5M | $-824.0K | $1M | $-2M | $-518.0K | $-628.0K | · | $-618.0K | $-481.0K | |
| Stockholders' Equity | $-94M | $-161M | $-123M | $-82M | $-46M | $-6M | $29M | $54M | $82M | $27M | $63M | $105M | $-63M | |
| Liabilities + Equity | $77M | $129M | $172M | $209M | $241M | $281M | $315M | $351M | $373M | $259M | · | $348M | $182M | |
| Shares Outstanding | 488,846,723 | 234,696,282 | 233,677,057 | 231,306,125 | 227,322,528 | 227,221,262 | 226,604,138 | 226,604,138 | 226,227,259 | 226,218,653 | 225,409,315 | 225,409,315 | 95,452,703 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $5.0K | $6.0K | $6.0K | $6.0K | $6.0K | $74.0K | $200.0K | $300.0K | $259.0K | $242.0K | $400.0K | $500.0K | |
| Stock-based Comp | $2M | $6M | $3M | $3M | $3M | $2M | $5M | $5M | $5M | $6M | $6M | $6M | $8M | |
| Other Non-cash | · | $2M | · | · | · | $-5M | · | · | · | $-16M | · | · | · | |
| Operating Cash Flow | $-39M | $-39M | $-48M | $-36M | $-47M | $-40M | $-35M | $-32M | $116M | $-52M | $-33M | $-34M | $-38M | |
| CapEx | $0 | $0 | $0 | $0 | $53.0K | $26.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $43M | $42M | $73M | $17M | $44M | $22M | $53M | $-27M | $-59M | $62M | $-14M | $-118M | $13M | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $-3M | · | · | · | |
| Financing Cash Flow | $-3M | $512.0K | $4M | $2M | $94.0K | $504.0K | $0 | $281.0K | $-9M | $-3M | $-3M | $198M | $-3M | |
| Net Change in Cash | $120.0K | $3M | $29M | $-17M | $-3M | $-17M | $18M | $-58M | $48M | $7M | $-50M | $46M | $-28M | |
| Free Cash Flow | · | $-39M | · | · | · | $-40M | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -282.2% | -264.6% | · | -369.4% | -337.4% | -372.2% | · | -357.8% | 54.4% | · | · | · | · | |
| Net Margin | 182.9% | -275.2% | · | -362.7% | -333.1% | -370.5% | · | -324.9% | 51.4% | · | · | · | · | |
| Pretax Margin | · | · | · | -362.7% | -333.1% | · | · | -336.9% | 56.0% | · | · | · | · | |
| EBITDA Margin | -282.2% | -264.6% | · | -369.4% | -337.4% | -372.2% | · | -355.7% | 54.7% | · | · | · | · | |
| ROA | 10.6% | -22.8% | · | -17.2% | -12.5% | -13.6% | · | -8.8% | 17.7% | -17.5% | · | -11.9% | -19.9% | |
| ROE | -24.1% | 55.6% | · | 342.0% | -216.1% | -357.9% | · | -38.8% | 525.7% | 4836.0% | · | -49.7% | 107.2% | |
| ROIC | · | · | · | 59.7% | 84.1% | · | · | -60.4% | 58.6% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 2.2 | · | 3.3 | 4.4 | 5.7 | · | 6.7 | 8.2 | 7.1 | · | 8.1 | 4.3 | |
| Quick Ratio | 0.5 | 1.9 | · | 3.1 | 4.1 | 5.5 | · | 6.5 | 7.9 | 6.8 | · | 7.8 | 4.0 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.1 | -0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | -0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -13.4 | · | -12.1 | -13.5 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.3 | · | · | · | · | |
| Receivables Turnover | 1.4 | 2.1 | · | 1.7 | 2.1 | 3.0 | · | 2.9 | 52.8 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.19 | $-0.69 | · | $-0.36 | $-0.20 | $-0.03 | · | $0.24 | $0.36 | $0.12 | · | $0.46 | $-0.66 | |
| Revenue / Share | $0.03 | $0.07 | · | $0.06 | $0.05 | $0.04 | · | $0.04 | $0.40 | · | · | · | · | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.18 | · | · | · | $-0.23 | · | · | · | |
| Cash / Share | $0.08 | $0.17 | · | $0.04 | $0.12 | $0.13 | · | $0.13 | $0.38 | $0.17 | · | $0.37 | $0.39 | |
| EPS (TTM) | $-0.70 | $-0.79 | · | $-0.68 | $-0.61 | $-0.22 | · | $-0.11 | $-0.18 | $-0.85 | · | $-1.74 | $-2.18 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $53M | $56M | · | $44M | $40M | $125M | · | $105M | $96M | $0 | · | · | · | |
| Net Income TTM | $-125M | $-180M | · | $-156M | $-139M | $-51M | · | $-72M | $-81M | $-173M | · | $-187M | $-207M | |
| Market Cap | $81M | $77M | · | $608M | $280M | $250M | · | $223M | $204M | $267M | · | $188M | $115M | |
| Enterprise Value | · | · | · | · | · | · | · | $-104M | $-151M | $32M | · | $-126M | $-30M | |
| P/E | -0.2 | -0.4 | · | -3.9 | -2.0 | -5.0 | · | -9.0 | -5.0 | -1.4 | · | -0.5 | -0.6 | |
| P/S | 1.5 | 1.4 | · | 13.8 | 6.9 | 2.0 | · | 2.1 | 2.1 | · | · | · | · | |
| P/B | -0.9 | -0.5 | · | -7.4 | -6.1 | -40.0 | · | 4.1 | 2.5 | 10.0 | · | 1.8 | -1.8 | |
| P / Tangible Book | · | · | · | · | · | · | · | 4.1 | 2.5 | 10.0 | · | 1.8 | · | |
| P / Cash Flow | · | -2.0 | · | · | · | -6.3 | · | · | · | -5.1 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | -1.0 | -1.6 | · | · | · | · | |
| Earnings Yield | -424.2% | -240.1% | · | -25.9% | -49.6% | -20.0% | · | -11.2% | -20.0% | -72.0% | · | -208.9% | -181.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $48M | $115M | $0 | $0 | · |
| Operating Margin % | -352.2% | -52.2% | · | · | · |
| Net Income | $-170M | $-57M | $-180M | $-229M | $-234M |
| Diluted EPS | $-0.75 | $-0.25 | $-1.18 | $-2.71 | $-3.13 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | 0.0 | 0.2 | 2.0 | 0.2 |
| Current Ratio | 2.6 | 6.9 | 5.9 | 5.3 | 8.3 |
| Quick Ratio | 2.4 | 6.7 | 5.7 | 5.2 | 8.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-171M | $-3M | $-159M | $-187M | $-190M |
Institutional owners (13F) 183 filers · $107.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
183
Value held
$107.0M
New positions
28
Exited positions
46
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 28 (-26 vs prior Q) | 46 (-6 vs prior Q) | 61 (-12 vs prior Q) | 47 (-5 vs prior Q) | +199.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $39,906,948 | 12,873,209 | 37.29% | Shares |
| TWO SIGMA ADVISERS, LP | $8,050,390 | 2,596,900 | 7.52% | Shares |
| D. E. Shaw & Co., Inc. | $6,741,898 | 40,959,285 | 6.30% | Shares |
| 683 Capital Management, LLC | $6,452,134 | 39,198,868 | 6.03% | Shares |
| DeepCurrents Investment Group LLC | $6,026,411 | 37,665,073 | 5.63% | Shares |
| Context Capital Management, LLC | $4,764,587 | 28,946,459 | 4.45% | Shares |
| Worth Venture Partners, LLC | $4,117,943 | 25,017,881 | 3.85% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $2,572,697 | 15,629,993 | 2.40% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $2,122,475 | 12,894,746 | 1.98% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,914,281 | 11,629,896 | 1.79% | Shares |
| Kalehua Capital Management LLC | $1,835,185 | 11,149,363 | 1.72% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,553,644 | 9,416,023 | 1.45% | Shares |
| ARCH Venture Management, LLC | $1,326,004 | 8,055,916 | 1.24% | Shares |
| BARCLAYS PLC | $1,289,233 | 7,832,522 | 1.20% | Shares |
| Octagon Capital Advisors LP | $1,275,650 | 7,750,000 | 1.19% | Shares |
| BlackRock, Inc. | $1,262,473 | 7,669,943 | 1.18% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,246,580 | 7,573,388 | 1.16% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,223,307 | 7,432,001 | 1.14% | Shares |
| SAMSARA BIOCAPITAL, LLC | $1,188,833 | 7,222,559 | 1.11% | Shares |
| Qube Research & Technologies Ltd | $1,163,023 | 7,065,756 | 1.09% | Shares |
| Corient Private Wealth LP | $927,142 | 5,632,698 | 0.87% | Shares |
| Siren, L.L.C. | $857,396 | 5,208,968 | 0.80% | Shares |
| HHLR ADVISORS, LTD. | $818,727 | 4,974,041 | 0.77% | Shares |
| UBS Group AG | $510,474 | 3,093,785 | 0.48% | Shares |
| Cubist Systematic Strategies, LLC | $428,125 | 162,785 | 0.40% | Shares |
| Squarepoint Ops LLC | $420,780 | 2,556,378 | 0.39% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $408,706 | 2,481,605 | 0.38% | Shares |
| MILLENNIUM MANAGEMENT LLC | $395,473 | 2,402,633 | 0.37% | Shares |
| MB Generational Wealth, LLC | $364,992 | 2,217,451 | 0.34% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $360,046 | 2,187,402 | 0.34% | Shares |
| MARSHALL WACE, LLP | $338,399 | 2,114,988 | 0.32% | Shares |
| Alyeska Investment Group, L.P. | $337,667 | 2,051,442 | 0.32% | Shares |
| WOLVERINE TRADING, LLC | $278,052 | 98,600 | 0.26% | Call option |
| HSBC HOLDINGS PLC | $267,389 | 1,583,118 | 0.25% | Shares |
| Ensign Peak Advisors, Inc | $238,831 | 1,450,979 | 0.22% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $205,490 | 1,245,392 | 0.19% | Shares |
| JPMORGAN CHASE & CO | $201,495 | 1,228,634 | 0.19% | Shares |
| DEUTSCHE BANK AG\ | $188,095 | 1,106,441 | 0.18% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $187,488 | 1,171,800 | 0.18% | Call option |
| GOLDMAN SACHS GROUP INC | $185,743 | 1,128,451 | 0.17% | Shares |
| STATE STREET CORP | $183,483 | 1,114,718 | 0.17% | Shares |
| NEA Management Company, LLC | $164,600 | 1,000,000 | 0.15% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $163,370 | 992,527 | 0.15% | Shares |
| SMITH, MOORE & CO. | $148,140 | 900,000 | 0.14% | Shares |
| Ishara Investments LP | $134,972 | 820,000 | 0.13% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $120,687 | 733,216 | 0.11% | Shares |
| CWM, LLC | $105,118 | 319,995 | 0.10% | Shares |
| Mariner, LLC | $97,889 | 594,719 | 0.09% | Shares |
| IEQ CAPITAL, LLC | $97,321 | 591,254 | 0.09% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $89,795 | 544,212 | 0.08% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| D. E. Shaw & Co., L.L.C., D. E. Shaw & Co., L.P., D. E. Shaw Valence Portfolios, L.L.C., David E. Shaw ×2 filings | Sept. 28, 2026 | 5.10% | Amendment | · | SEC |
| D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw & Co., L.L.C., D. E. Shaw & Co., L.P., David E. Shaw ×3 filings | July 24, 2026 | 7.10% | Amendment | · | SEC |
| Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×2 filings | Feb. 24, 2026 | 1.70% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 21 insiders · 10 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Faheem Hasnain | President & CEO | Aug. 24, 2026 A | 837,793 | 0 | 0 | $0 |
| Sheila Gujrathi | President & CEO | Feb. 14, 2020 A | 189,500 | 0 | 0 | $0 |
| Bryan Giraudo | COO/CFO | Aug. 24, 2026 A | 389,737 | 0 | 0 | $0 |
| Robert Paul Smith JR | Chief Commercial Officer | Aug. 24, 2026 A | 260,898 | 0 | 0 | $0 |
| Caryn Peterson | Chief Development Officer | Aug. 24, 2026 A | 259,333 | 0 | 0 | $0 |
| Waage Christian | EVP, Tech Ops and Admin | Aug. 24, 2026 A | 814,061 | 0 | 0 | $0 |
| Richard Aranda | Chief Medical Officer | March 19, 2026 A | 463,106 | 0 | 0 | $0 |
| Laura Carter | Chief Scientific Officer | March 20, 2023 A | 76,263 | 0 | 0 | $0 |
| Luisa Salter-Cid | Chief Scientific Officer | March 23, 2021 S | 206,065 | 0 | 0 | $0 |
| Jakob Dupont | Chief Medical Officer | Feb. 14, 2020 A | 46,500 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Director | Sept. 23, 2026 A | · | 0 | 0 | $0 |
| Steven D Nathan | Director | Sept. 23, 2026 A | · | 0 | 0 | $0 |
| Skye Drynan | Director | Sept. 23, 2026 A | · | 0 | 0 | $0 |
| Sandra Milligan | Director | Sept. 23, 2026 A | 58,050 | 0 | 0 | $0 |
| John D Quisel | Director | Sept. 23, 2026 A | · | 0 | 0 | $0 |
| Thomas O Daniel | Director | Sept. 23, 2026 A | 38,095 | 0 | 0 | $0 |
| Russell J. Cox | Director | Sept. 23, 2026 A | 7,200 | 0 | 0 | $0 |
| Renee D Gala | Director | June 8, 2023 A | · | 0 | 0 | $0 |
| Kristina Burow | Director | June 8, 2023 A | 4,027,958 | 0 | 0 | $0 |
| Joshua H. Bilenker | Director | June 9, 2022 A | · | 0 | 0 | $0 |
| Otello Stampacchia | Director | June 10, 2019 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 7 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| ESSC · Strategy Shares | 0.10% | 204,551 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.00% | 3,386,123 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.00% | 420 SH | Oct. 1, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 6,968 SH | Oct. 1, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 2,243,305 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 6,910,934 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.00% | 544,212 SH | Aug. 19, 2026 | Daily |
GOSS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$90.00
+740.3%
3 21.4%
Strong Buy
6 42.9%
Buy
4 28.6%
Hold
1 7.1%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-27Mean target $82.48 +670.1%
← Below all targets
Current price $10.71
Low$22.40
Mean$82.48
High$120.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | · |
| XBIT | · | -1.6 | · | · | · | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| APLM | · | -2.5 | · | -128.7% | -1305.4% | · |
| FBIO | · | · | · | · | · | · |
| NMAD | · | · | · | · | · | · |
| INKT | · | -3.8 | 4.5% | -6931.8% | 63.4% | · |
| FRMM | · | · | · | -6881.3% | -368.1% | · |
| ACET | · | -0.5 | · | · | · | · |
| BOLD | $27M | -0.5 | · | · | -46.7% | · |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026